Lexology January 23, 2025
BRG

THREE IN TEN ASSUME CONTINUED CHOPPINESS IN EARLY 2025, THEN 85% PROJECT MORE DEALS Investment in healthcare is expected to pick up in 2025, likely midyear, even amid some uncertainty with changes in the federal government. Competition will be significant as nearly three-quarters of the 127 investors plan to focus on three of the most promising sectors: (1) infusion pharmacy, buoyed by a robust pipeline with 60% of the drugs in IV form; (2) behavioral health, which has become a must-have for portfolios given the ongoing mental health crisis; and (3) services focused on care in the home, principally paid by government, and driven by either tech or staffing, or both. Despite these compelling opportunities, for the first time in...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Investments, Trends
Zoom invests in AI startup Suki
What's next for healthcare private equity?
BridgeBio Oncology to Go Public in SPAC Deal Bringing $450M+ for Trio of Cancer Drugs
Private equity deal would set stage for 3-way Walgreens split: Report
Rare Disease Biotech Zevra Therapeutics to Sell FDA Drug Review Fast Pass for $150M

Share This Article